Portfolio concentration
As of April 30, 2026 · N-PORT
Holdings
147
Top-10 weight
39.06%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
11
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
965.0
Holdings
As of April 30, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | US ULTRA BOND CBT Sep25 | — | 15,471,000 | $15.47M | 8.47% |
| 2 | US ULTRA BOND CBT Sep25 | — | 13,150,000 | $13.15M | 7.20% |
| 3 | US ULTRA BOND CBT Sep25 | — | 11,603,000 | $11.60M | 6.36% |
| 4 | US ULTRA BOND CBT Sep25 | — | 7,735,000 | $7.74M | 4.24% |
| 5 | US ULTRA BOND CBT Sep25 | — | 3,847,000 | $3.85M | 2.11% |
| 6 | Invesco Government & Agency Portfolio, Institutional Class | — | 3,746,290 | $3.75M | 2.05% |
| 7 | US ULTRA BOND CBT Sep25 | — | 2,707,000 | $2.71M | 1.48% |
| 8 | APELLIS PHARMACEUTICALS INC | — | 60,117 | $2.46M | 1.35% |
| 9 | REVOLUTION MEDICINES INC | — | 15,087 | $2.17M | 1.19% |
| 10 | TRAVERE THERAPEUTICS INC | — | 50,777 | $2.14M | 1.17% |
| 11 | ARROWHEAD PHARMACEUTICALS INC | — | 25,860 | $1.90M | 1.04% |
| 12 | TWIST BIOSCIENCE CORP | — | 32,063 | $1.87M | 1.03% |
| 13 | SUMMIT THERAPEUTICS INC | — | 86,301 | $1.85M | 1.01% |
| 14 | ALKERMES PLC | — | 54,105 | $1.82M | 1.00% |
| 15 | TG THERAPEUTICS INC | — | 53,565 | $1.81M | 0.99% |
| 16 | MADRIGAL PHARMACEUTICALS INC | — | 3,482 | $1.80M | 0.99% |
| 17 | BEAM THERAPEUTICS INC | — | 57,611 | $1.75M | 0.96% |
| 18 | APOGEE THERAPEUTICS INC | — | 20,119 | $1.67M | 0.91% |
| 19 | SCHOLAR ROCK HOLDING CORP | — | 34,796 | $1.62M | 0.89% |
| 20 | PRAXIS PRECISION MEDICINES INC | — | 5,059 | $1.61M | 0.88% |
| 21 | EXELIXIS INC | — | 35,988 | $1.60M | 0.88% |
| 22 | MIRUM PHARMACEUTICALS INC | — | 16,376 | $1.59M | 0.87% |
| 23 | UNITED THERAPEUTICS CORP DEL | — | 2,758 | $1.58M | 0.86% |
| 24 | NATERA INC | — | 7,642 | $1.58M | 0.86% |
| 25 | CRISPR Therapeutics A.G. Series A | CRSP US | 30,092 | $1.58M | 0.86% |
| 26 | CELCUITY INC | — | 12,979 | $1.58M | 0.86% |
| 27 | KRYSTAL BIOTECH INC | — | 5,892 | $1.55M | 0.85% |
| 28 | PROTAGONIST THERAPEUTICS INC | — | 15,573 | $1.54M | 0.84% |
| 29 | NEUROCRINE BIOSCIENCES INC | — | 11,599 | $1.53M | 0.84% |
| 30 | INCYTE CORP | — | 15,873 | $1.51M | 0.83% |
| 31 | CG ONCOLOGY INC | — | 22,645 | $1.51M | 0.83% |
| 32 | CYTOKINETICS INC | — | 23,613 | $1.51M | 0.83% |
| 33 | NUVALENT INC-A | — | 15,017 | $1.51M | 0.82% |
| 34 | IONIS PHARMACEUTICALS INC | — | 20,089 | $1.50M | 0.82% |
| 35 | BRIDGEBIO PHARMA INC | — | 21,046 | $1.50M | 0.82% |
| 36 | VAXCYTE INC | — | 26,117 | $1.49M | 0.82% |
| 37 | KYMERA THERAPEUTICS INC | — | 18,431 | $1.49M | 0.82% |
| 38 | BIOGEN INC | — | 7,888 | $1.49M | 0.82% |
| 39 | COGENT BIOSCIENCES INC | — | 41,643 | $1.49M | 0.82% |
| 40 | PTC THERAPEUTICS INC | — | 22,879 | $1.49M | 0.82% |
| 41 | INSMED INC | — | 10,778 | $1.47M | 0.80% |
| 42 | ALNYLAM PHARMACEUTICALS INC | — | 4,689 | $1.45M | 0.79% |
| 43 | ROIVANT SCIENCES | — | 50,794 | $1.45M | 0.79% |
| 44 | HALOZYME THERAPEUTICS INC | — | 22,601 | $1.44M | 0.79% |
| 45 | ARCUTIS BIOTHERAPEUTICS INC | — | 60,967 | $1.42M | 0.78% |
| 46 | SPYRE THERAPEUTICS INC | — | 18,961 | $1.41M | 0.77% |
| 47 | SOLENO THERAPEUTICS INC | — | 26,523 | $1.40M | 0.77% |
| 48 | ABBVIE INC | — | 6,599 | $1.39M | 0.76% |
| 49 | AMGEN INC | — | 3,979 | $1.38M | 0.75% |
| 50 | REGENERON PHARMACEUTICALS INC | — | 1,940 | $1.37M | 0.75% |
1 / 4
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.